Literature DB >> 33542709

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI.

Bo Sun1,2,3,4, Yujia Ma1,2,3,4, Lu Li1,2,3,4, Linli Hu1,2,3,4, Fang Wang1,2,3,4, Yile Zhang1,2,3,4, Shanjun Dai1,2,3,4, Yingpu Sun1,2,3,4.   

Abstract

Introduction: Age, polycystic ovary syndrome (PCOS), low body mass index (BMI), high antral follicle count (AFC), increased anti-Muller hormone (AMH) levels, and elevated serum estradiol (E2) concentrations are risk factors for ovarian hyperstimulation syndrome (OHSS). However, data on the relationship between risk factors and OHSS severity in patients with PCOS are rare. Objective: This retrospective study examined the risk factors for OHSS and their effect on OHSS severity in patients with PCOS undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI). Method: The records of 2,699 women were reviewed and included in this study. These women were diagnosed with PCOS during their first IVF/ICSI cycle between January 2010 and December 2017. We analyzed the association between each of the interrogated risk factors (including female age, BMI, AFC, basal serum E2, and the number of oocytes retrieved) and OHSS. The effects of each risk factor on OHSS severity were further explored. Logistic regression was performed as part of the above analysis.
Results: Of the 2,699 women with PCOS who underwent assisted reproductive technology (ART), 75.2% had a normal response to controlled ovarian hyperstimulation (COH), while 24.8% developed OHSS. All OHSS patients were younger and had lower BMIs and basal serum follicle-stimulating hormone (FSH) and E2 levels but higher AFCs than those in the normal group. AFC demonstrated a strong correlation with OHSS, with a cutoff value of 24 in patients with PCOS. A total of 19.5% of the patients had mild OHSS, while 80.5% had moderate OHSS. Compared with those in the moderate OHSS group, those in the mild OHSS group were older and had higher basal serum FSH levels and lower serum E2 and T levels. However, BMI and AFC were not different between the mild and moderate OHSS groups. Basal serum E2 showed a strong correlation with OHSS severity, with a cutoff value of 37.94 pg/ml. Conclusions: AFC is a strong marker of OHSS, and basal serum E2 is the best predictor of OHSS severity in women with PCOS undergoing IVF treatment.
Copyright © 2021 Sun, Ma, Li, Hu, Wang, Zhang, Dai and Sun.

Entities:  

Keywords:  antral follicle count; body mass index; estradiol; ovarian hyperstimulation syndrome; polycystic ovarian syndrome

Mesh:

Substances:

Year:  2021        PMID: 33542709      PMCID: PMC7851086          DOI: 10.3389/fendo.2020.615957

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  34 in total

1.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

Review 2.  British Fertility Society Policy and Practice Committee: prevention of ovarian hyperstimulation syndrome.

Authors:  R S Mathur; B K Tan
Journal:  Hum Fertil (Camb)       Date:  2014-11-07       Impact factor: 2.767

3.  Serum müllerian-inhibiting substance levels during normal menstrual cycles.

Authors:  C L Cook; Y Siow; S Taylor; M E Fallat
Journal:  Fertil Steril       Date:  2000-04       Impact factor: 7.329

4.  Predictive factors of early moderate/severe ovarian hyperstimulation syndrome in non-polycystic ovarian syndrome patients: a statistical model.

Authors:  Mahnaz Ashrafi; Akram Bahmanabadi; Mohammad Reza Akhond; Arezoo Arabipoor
Journal:  Arch Gynecol Obstet       Date:  2015-04-29       Impact factor: 2.344

5.  Moderate-to-severe ovarian hyperstimulation syndrome: A retrospective multivariate logistic regression analysis in Chinese patients.

Authors:  Tianzhong Ma; Yanru Niu; Bing Wei; Lihua Xu; Lin Zou; Xiaoqun Che; Xiao Wang; Di Tang; Riyan Huang; Bi Chen
Journal:  Adv Clin Exp Med       Date:  2020-01       Impact factor: 1.727

Review 6.  Adiponectin and polycystic ovary syndrome.

Authors:  Susan W Groth
Journal:  Biol Res Nurs       Date:  2010-05-24       Impact factor: 2.522

Review 7.  Polycystic ovary syndrome.

Authors:  Robert J Norman; Didier Dewailly; Richard S Legro; Theresa E Hickey
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

8.  Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study.

Authors:  George T Lainas; Tryfon G Lainas; Ioannis A Sfontouris; Christos A Venetis; Julia K Bosdou; Aikaterini Chatzimeletiou; Grigorios F Grimbizis; Basil C Tarlatzis; Efstratios M Kolibianakis
Journal:  Reprod Biomed Online       Date:  2019-10-15       Impact factor: 3.828

Review 9.  Basic infertility including polycystic ovary syndrome.

Authors:  Maryse Brassard; Youssef AinMelk; Jean-Patrice Baillargeon
Journal:  Med Clin North Am       Date:  2008-09       Impact factor: 5.456

10.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.

Authors:  Neil F Goodman; Rhoda H Cobin; Walter Futterweit; Jennifer S Glueck; Richard S Legro; Enrico Carmina
Journal:  Endocr Pract       Date:  2015-11       Impact factor: 3.443

View more
  6 in total

1.  Follicular fluid PlGF and IVF/ICSI outcomes among PCOS and normo-ovulatory women using different controlled hyperstimulation protocols: A prospective case-control study.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Ann Med Surg (Lond)       Date:  2022-06-25

2.  Transcriptomic landscape of granulosa cells and peripheral blood mononuclear cells in women with PCOS compared to young poor responders and women with normal response.

Authors:  Mauro Cozzolino; Sonia Herraiz; Shiny Titus; Leah Roberts; Monica Romeu; Irene Peinado; Richard T Scott; Antonio Pellicer; Emre Seli
Journal:  Hum Reprod       Date:  2022-05-30       Impact factor: 6.353

3.  Clinical Pregnancy and Incidence of Ovarian Hyperstimulation Syndrome in High Ovarian Responders Receiving Different Doses of hCG Supplementation in a GnRH-Agonist Trigger Protocol.

Authors:  Xiuzhen Shen; Qinjie Yang; Lanfang Li; Wenhao Lu
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-25       Impact factor: 2.629

4.  Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis.

Authors:  Sally Kadoura; Marwan Alhalabi; Abdul Hakim Nattouf
Journal:  Sci Rep       Date:  2022-03-15       Impact factor: 4.379

Review 5.  Effect of TSH on oocyte maturation of PCOS patients with normal thyroid function in IVF.

Authors:  Shaoyuan Xu; Cancan Qiang; Ying Zhang; Changjun Zhang
Journal:  Reprod Biol Endocrinol       Date:  2022-09-02       Impact factor: 4.982

6.  Development and Validation of Prediction Model for High Ovarian Response in In Vitro Fertilization-Embryo Transfer: A Longitudinal Study.

Authors:  Xinsha Tan; Honglin Xi; Jing Yang; Wenfeng Wang
Journal:  Comput Math Methods Med       Date:  2021-10-16       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.